NELSEN ROBERT
- SEC CIK
- 0001219042
Latest role at each company
- BOLD Boundless Bio, Inc.10% Owneras of Jul 6, 2026
- KARD Kardigan, Inc.Director, 10% Owneras of Jun 24, 2026
- PRME Prime Medicine, Inc.Director, 10% Owneras of Jun 8, 2026
- SANA Sana Biotechnology, Inc.Director, 10% Owneras of Jun 5, 2026
- SPTX Seaport Therapeutics, Inc.10% Owneras of May 4, 2026
Show 9 more companies
- LYEL Lyell Immunopharma, Inc.10% Owneras of Mar 9, 2026
- CIK 0002040807Director, 10% Owneras of Nov 14, 2025
- NMRA Neumora Therapeutics, Inc.10% Owneras of Oct 29, 2025
- RAPP Rapport Therapeutics, Inc.10% Owneras of Jun 10, 2024
- VIR Vir Biotechnology, Inc.Directoras of Jun 3, 2024
- CIK 000186329410% Owneras of Aug 10, 2023
- CIK 000165935210% Owneras of Sep 15, 2022
- ERAS Erasca, Inc.10% Owneras of Jul 20, 2021
- BEAM Beam Therapeutics Inc.10% Owneras of Jul 2, 2021
Trades
Every Form 4 that lists NELSEN ROBERT as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| BOLDBoundless Bio, Inc. | Jul 6, 20265:44 PM ET | Jul 1, 2026 | CRANDELL KEITH and 4 others10% Owner | SSaleCommon Stock | −16K | $2.49 | −$39.84K | 0 | −100.0% | SEC |
| KARDKardigan, Inc. | Jun 24, 20264:18 PM ET | Jun 22, 2026 | CRANDELL KEITH and 6 othersDirector, 10% Owner | PPurchaseCommon Stock | +1.25M | $16.00 | +$20M | 15.04M | +9.1% | SEC |
| SPTXSeaport Therapeutics, Inc. | May 4, 20266:02 PM ET | May 4, 2026 | CRANDELL KEITH and 6 others10% Owner | PPurchaseCommon Stock | +1.1M | $18.00 | +$19.8M | 6.29M | +21.2% | SEC |
| LYELLyell Immunopharma, Inc. | Mar 9, 20264:34 PM ET | Mar 6, 2026 | BERNS PAUL L and 8 others10% Owner | PPurchaseCommon Stock | +488.09K | $25.61 | +$12.5M | 1.43M | +52.0% | SEC |
| NMRANeumora Therapeutics, Inc. | Oct 29, 20257:21 PM ET | Oct 27, 2025 | CRANDELL KEITH and 6 others10% Owner | PPurchaseCommon Stock | +1.92M | $2.61 | +$5M | 6.05M | +46.4% | SEC |
| PRMEPrime Medicine, Inc. | Aug 1, 2025 | Aug 1, 2025 | NELSEN ROBERTDirector, 10% Owner | PPurchaseCommon Stock | +3.03M | $3.30 | +$10M | 6.23M | +94.7% | SEC |
| – | Feb 3, 20257:01 PM ET | Feb 3, 2025 | CRANDELL KEITH and 8 others10% Owner | PPurchaseCommon Stock | +2.22M | $18.00 | +$40M | 8.31M | +36.5% | SEC |
| BOLDBoundless Bio, Inc. | Apr 4, 20244:30 PM ET | Apr 2, 2024 | CRANDELL KEITH and 3 others10% Owner | PPurchaseCommon Stock | +200K | $16.00 | +$3.2M | 1.18M | +20.4% | SEC |
| PRMEPrime Medicine, Inc. | Feb 20, 2024 | Feb 15, 2024 | NELSEN ROBERTDirector, 10% Owner | PPurchaseCommon Stock | +3.2M | $6.25 | +$20M | 3.2M | New position | SEC |
| SANASana Biotechnology, Inc. | Feb 12, 2024 | Feb 8, 2024 | NELSEN ROBERTDirector, 10% Owner | PPurchaseCommon Stock | +1.82M | $5.50 | +$10M | 12.45M | +17.1% | SEC |
| NMRANeumora Therapeutics, Inc. | Nov 15, 20236:54 PM ET | Nov 13 – Nov 14, 2023 | CRANDELL KEITH and 5 others10% Owner | PPurchaseCommon Stock | +35.01K | $11.7721 | +$412.14K | 4.13M | +0.9% | SEC |
| NMRANeumora Therapeutics, Inc. | Nov 13, 20237:00 PM ET | Nov 8 – Nov 10, 2023 | CRANDELL KEITH and 5 others10% Owner | PPurchaseCommon Stock | +140.61K | $10.978 | +$1.54M | 4.1M | +3.6% | SEC |
| NMRANeumora Therapeutics, Inc. | Nov 7, 20236:59 PM ET | Nov 3 – Nov 7, 2023 | CRANDELL KEITH and 5 others10% Owner | PPurchaseCommon Stock | +95.69K | $11.4944 | +$1.1M | 3.96M | +2.5% | SEC |
| NMRANeumora Therapeutics, Inc. | Sep 29, 20236:53 PM ET | Sep 28 – Sep 29, 2023 | CRANDELL KEITH and 5 others10% Owner | PPurchaseCommon Stock | +76.51K | $13.6823 | +$1.05M | 3.86M | +2.0% | SEC |
| NMRANeumora Therapeutics, Inc. | Sep 27, 20238:18 PM ET | Sep 26 – Sep 27, 2023 | CRANDELL KEITH and 5 others10% Owner | PPurchaseCommon Stock | +58.5K | $11.9729 | +$700.46K | 3.78M | +1.6% | SEC |
| NMRANeumora Therapeutics, Inc. | Sep 25, 20239:38 PM ET | Sep 22 – Sep 25, 2023 | CRANDELL KEITH and 5 others10% Owner | PPurchaseCommon Stock | +100.74K | $11.1878 | +$1.13M | 3.72M | +2.8% | SEC |
| NMRANeumora Therapeutics, Inc. | Sep 20, 20236:16 AM ET | Sep 19, 2023 | CRANDELL KEITH and 7 others10% Owner | PPurchaseCommon Stock | +1.5M | $17.00 | +$25.5M | 3.62M | +70.6% | SEC |
| PRMEPrime Medicine, Inc. | Oct 26, 2022 | Oct 24, 2022 | NELSEN ROBERTDirector, 10% Owner | PPurchaseCommon Stock | +800K | $17.00 | +$13.6M | 6.13M | +15.0% | SEC |
| – | Sep 15, 20226:53 PM ET | Sep 13, 2022 | CRANDELL KEITH and 6 others10% Owner | PPurchaseCommon Sotck | +5M | $1.50 | +$7.5M | 8.85M | +129.7% | SEC |
| – | Sep 15, 20226:53 PM ET | Sep 13, 2022 | CRANDELL KEITH and 6 others10% Owner | PPurchaseCommon Stock · Derivative | +5M | – | – | 5M | – | SEC |
| – | Aug 3, 20219:06 PM ET | Jul 30, 2021 | NELSEN ROBERT and 5 others10% Owner | PPurchaseClass A Common Stock | +1.6M | $10.00 | +$16M | 1.6M | New position | SEC |